RESUMEN
Previously, we demonstrated that extracts of the ripe fruit (rPM) and unripe fruit (uPM) of Prunus mume (Siebold) Siebold & Zucc. and citric acid have a laxative effect, which is at least partially mediated by the increase in fecal parameters as seen in the low-fiber diet-induced constipation model rats. This study aims at investigating the laxative effects of citric acid-enriched aqueous extracts of rPM, uPM, and its active compounds, such as citric acid and malic acid, on loperamide-induced constipation rat models. Animal studies were conducted with loperamide-induced constipation animal models. The results showed that rPM and citric acid, the major organic acid compounds, significantly improved stool parameters (number, weight, and water content of the stools) generated in loperamide-induced constipation rats, without adverse effects of diarrhea. The gastrointestinal (GI) motility was activated fully in the rPM- and citric acid-treated rats than in rats treaded with loperamide alone. In addition, when rPM and citric acid were added to RAW264.7 cells and used to treat loperamide-induced constipation model rats, the secretion of prostaglandin E2 (PGE2) increased significantly in cells and tissue. Furthermore, rPM and citric acid decreased the expression of the aquaporin 3 (AQP3) in the rat colons. Our results demonstrated that rPM and citric acid, the major organic acid compound in rPM, can effectively promote defecation frequency and regulate PGE2 secretion and AQP3 expression in the colon, providing scientific evidence to support the use of rPM as a therapeutic application.
Asunto(s)
Laxativos , Prunus , Animales , Acuaporina 3 , Ácido Cítrico/uso terapéutico , Estreñimiento/inducido químicamente , Estreñimiento/tratamiento farmacológico , Loperamida , Prostaglandinas/uso terapéutico , Prostaglandinas E/uso terapéutico , RatasRESUMEN
Background and Objectives: This study aimed at investigating the laxative effects of a standardized aqueous extract of Dendropanax morbiferus H. Lév. on two different constipation rat models. Materials and Methods: Animal studies were conducted with low-fiber diet-induced and loperamide-induced constipation animal models, and isolated colons were used in ex vivo analysis to determine the changes in colonic motility caused by D. morbiferus H. Lév. leaf extract (DPL). Results: The results showed that DPL administration significantly improved certain reduced fecal parameters (number, weight, and water content of the stools) in a both low-fiber diet and loperamide-induced constipation models without adverse effects of diarrhea. The laxative effect of DPL was confirmed to improve the charcoal excretion time upon DPL treatment in a low-fiber diet or loperamide-induced constipation model through gastrointestinal (GI) motility evaluation using the charcoal meal test. In addition, when DPL was administered to RAW264.7 cells and loperamide-induced constipation model rats, the production of prostaglandin E2 (PGE2) increased significantly in cells and tissue. Furthermore, DPL dose-dependently stimulated the spontaneous contractile amplitude and frequency of the isolated rat colon. Conclusion: Although our study did not provide information on the acute or chronic toxicity of DPL, our results demonstrated that DPL can effectively promote defecation frequency and rat colon contraction, providing scientific evidence to support the use of DPL as a therapeutic application. However, further toxicity studies of DPL are needed prior to the initiation of clinical trials and clinical applications.
Asunto(s)
Laxativos , Extractos Vegetales , Animales , Estreñimiento/inducido químicamente , Estreñimiento/tratamiento farmacológico , Motilidad Gastrointestinal , Laxativos/farmacología , Laxativos/uso terapéutico , Loperamida/farmacología , Loperamida/uso terapéutico , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , RatasRESUMEN
Previously, we demonstrated that a 5% ethanol extract of unripe Rubus coreanus (5-uRCK) and ellagic acid has hypocholesterolemic and antiobesity activity, at least partially mediated by the downregulation of adipogenic and lipogenic gene expression in high-fat diet (HFD)-fed animals. The present study investigated the thermogenic and lipolytic antiobesity effects of 5-uRCK and ellagic acid in HFD-induced obese C57BL/6 mice and explored its mechanism of action. Mice fed an HFD received 5-uRCK or ellagic acid as a post-treatment or pretreatment. Both post-treated and pretreated mice showed significant reductions in body weight and adipose tissue mass compared to the HFD-fed mice. The protein levels of lipolysis-associated proteins, such as adipose triglyceride lipase (ATGL), phosphorylated hormone-sensitive lipase (p-HSL), and perilipin1 (PLIN1), were significantly increased in both the 5-uRCK- and ellagic acid-treated mouse epididymal white adipose tissue (eWAT). Additionally, thermogenesis-associated proteins, such as peroxisome proliferator-activated receptor α (PPARα), carnitine palmitoyl transferase-1 (CPT1), uncoupling protein 1 (UCP1), and peroxisome proliferator-activated receptor-γ coactivator-1α (PGC1α), in inguinal white adipose tissue (ingWAT) were clearly increased in both the 5-uRCK- and ellagic acid-treated mice compared to HFD-fed mice. These results suggest that 5-uRCK and ellagic acid are effective for suppressing body weight gain and enhancing the lipid profile.
Asunto(s)
Ácido Elágico/química , Lipólisis/efectos de los fármacos , Extractos Vegetales/farmacología , Rubus/química , Termogénesis/efectos de los fármacos , Adipogénesis/genética , Tejido Adiposo Blanco/efectos de los fármacos , Tejido Adiposo Blanco/metabolismo , Tejido Adiposo Blanco/patología , Animales , Biomarcadores/metabolismo , Peso Corporal/efectos de los fármacos , Dieta Alta en Grasa , Regulación hacia Abajo/efectos de los fármacos , Ácido Elágico/administración & dosificación , Ácido Elágico/aislamiento & purificación , Ácido Elágico/farmacología , Lipogénesis/genética , Masculino , Ratones , Ratones Endogámicos C57BL , Obesidad/tratamiento farmacológico , Obesidad/veterinaria , PPAR alfa/genética , PPAR alfa/metabolismo , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Rubus/metabolismo , Proteína Desacopladora 1/genética , Proteína Desacopladora 1/metabolismoRESUMEN
Our previous study demonstrated that a 5% ethanol extract of unripe Rubus coreanus (5-uRCK) has hypo-cholesterolemic and anti-obesity activity. However, the molecular mechanisms of its effects are poorly characterized. We hypothesized that 5-uRCK and one of its major bioactive compounds, ellagic acid, decrease cellular and plasma cholesterol levels. Thus, we investigated the hypocholesterolemic activity and mechanism of 5-uRCK in both hepatocytes and a high-cholesterol diet (HCD)-induced rat model. Cholesterol in the liver and serum was significantly reduced by 5-uRCK and ellagic acid. The hepatic activities of HMG-CoA and CETP were reduced, and the hepatic activity of LCAT was increased by both 5-uRCK extract and ellagic acid, which also caused histological improvements. The MDA content in the aorta and serum was significantly decreased after oral administration of 5-uRCK or ellagic acid. Further immunoblotting analysis showed that AMPK phosphorylation in the liver was induced by 5-uRCK and ellagic acid, which activated AMPK, inhibiting the activity of HMGCR by inhibitory phosphorylation. In contrast, 5-uRCK and ellagic acid suppressed the nuclear translocation and activation of SREBP-2, which is a key transcription factor in cholesterol biosynthesis. In conclusion, our results suggest that 5-uRCK and its bioactive compound, ellagic acid, are useful alternative therapeutic agents to regulate blood cholesterol.
Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Colesterol/metabolismo , Ácido Elágico/farmacología , Hidroximetilglutaril-CoA Reductasas/metabolismo , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Proteínas de la Membrana/metabolismo , Extractos Vegetales/farmacología , Rubus/química , Proteína 2 de Unión a Elementos Reguladores de Esteroles/metabolismo , Animales , Antioxidantes/metabolismo , Peso Corporal/efectos de los fármacos , Colesterol/sangre , Proteínas de Transferencia de Ésteres de Colesterol/metabolismo , Dieta Alta en Grasa , Ácido Elágico/uso terapéutico , Células Hep G2 , Hepatocitos/metabolismo , Humanos , Hipercolesterolemia/tratamiento farmacológico , Metabolismo de los Lípidos/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Tamaño de los Órganos/efectos de los fármacos , Fosfatidilcolina-Esterol O-Aciltransferasa/metabolismo , Fosforilación/efectos de los fármacos , Extractos Vegetales/uso terapéutico , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacosRESUMEN
Our previous results suggest that the Rosa rugosa Thunb. (family Rosaceae) alleviates endurance exercise-induced stress by decreasing oxidative stress levels. This study aimed to screen and identify the physiological antistress effects of an extract of R. rugosa (RO) on sleep deprivation-induced anxiety-like behavior and cognitive tests (in vivo) and tested for hippocampal CORT and monoamine levels (ex vivo), corticosterone (CORT)-induced injury, N-methyl-d-aspartate (NMDA) receptor, and serotonin 6 (5-hydroxytryptamine 6, 5-HT6) receptor activities (in vitro) in search of active principles and underlying mechanisms of action. We confirmed the antistress effects of RO in a sleep-deprived stress model in rat and explored the underlying mechanisms of its action. In conclusion, an R. rugosa extract showed efficacy and potential for use as an antistress therapy to treat sleep deprivation through its antagonism of the 5-HT6 receptor and resulting inhibition of cAMP activity.
Asunto(s)
Ansiedad/metabolismo , Disfunción Cognitiva/metabolismo , Extractos Vegetales/farmacología , Receptores de Serotonina/metabolismo , Rosa , Privación de Sueño/psicología , Estrés Fisiológico/efectos de los fármacos , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Ansiedad/tratamiento farmacológico , Conducta Animal , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Disfunción Cognitiva/tratamiento farmacológico , Corticosterona/metabolismo , AMP Cíclico/antagonistas & inhibidores , Dopamina/metabolismo , Masculino , Fitoterapia , Extractos Vegetales/uso terapéutico , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismo , Serotonina/sangre , Sueño/fisiología , Privación de Sueño/complicaciones , Privación de Sueño/metabolismoRESUMEN
Maesil (the fruit of Prunus mume Siebold & Zucc.) has long been used as an alternative medicine and functional food in Korea and Japan for preventive and therapeutic purposes. We examined the laxative effect of unripe Maesil (UM) and ripe Maesil (RM) in a rat model on constipation induced by a low-fibre diet and the possible mechanisms of Maesil in the rat colon. In vivo studies were conducted on the low-fibre diet-induced constipation rat model, and isolated rat colon was used in in vitro experiments to measure the changes in spontaneous colon contraction generated by Maesil and organic acids as standard and effectual ingredients, respectively. The aqueous extract of both UM and RM applied orally (100 and 300 mg/kg) produced significant increase of faeces frequency (p < 0.05) and moisture (p < 0.001). Moreover, the number faecal pellets number was reduced (p < 0.05) in the distal colons of the Maesil-treated rats. Gastrointestinal (GI) motility, measured by charcoal meal, was activated more fully by UM than in the low-fibre diet group. Both UM and RM and its organic acids produced a dose-dependent stimulation of the spontaneous contractile amplitude (p < 0.001) and frequency (p < 0.01) of the isolated rat colon. Although both UM and RM were an effective laxative, the RM was significantly more effective than the UM in the in vivo and in vitro constipation experiments because of the changes in the composition of organic acids during the ripening of the fruit. Our results demonstrated that Maesil was effective in promoting the frequency of defaecation and contraction of the rat colon, which provided scientific basis to support the use of Maesil as potential therapeutics in treating constipation.
Asunto(s)
Colon/efectos de los fármacos , Estreñimiento/tratamiento farmacológico , Defecación/efectos de los fármacos , Fibras de la Dieta/deficiencia , Laxativos/uso terapéutico , Fitoterapia , Prunus/química , Ácidos/farmacología , Ácidos/uso terapéutico , Animales , Estreñimiento/etiología , Dieta/efectos adversos , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Heces , Frutas/química , Motilidad Gastrointestinal/efectos de los fármacos , Laxativos/farmacología , Masculino , Contracción Muscular , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Sprague-DawleyRESUMEN
CONTEXT: Chamaecyparis obtusa Sieb. & Zucc., Endlicher (Cupressaceae) forest bathing or aromatherapy has been shown in various studies to have biological functions such as anticancer, antiallergies, antiinflammatory, and antioxidant activity. However, no reports exist on the pharmacological or biological activities of the essential oil of C. obtusa (EOCO) or its effects on central nervous system. OBJECTIVE: The aggregation and formation of ß-amyloid peptides (Aß) into fibrils are central events in the pathogenesis of Alzheimer's disease (AD), and overproduction and aggregation of Aß into oligomers have been known to trigger neurotoxicity. In this study, we investigated the effects of inhaled EOCO on cognitive function and neuronal apoptosis in rats intrahippocampally injected with Aß. MATERIALS AND METHODS: To model AD, 4 µg of aggregated Aß was injected into the hippocampus. To test the effects of EOCO, behavioral performance in the Morris water maze was tested 4 days after injection. After behavioral testing, brain sections were prepared for TTC staining and TUNEL assay. RESULTS: Inhaled EOCO protected spatial learning and memory from the impairments induced by Aß(1-40) injection. In addition, the behavioral deficits accompanying Aß(1-40)-induced AD were attenuated by inhalation of EOCO. Furthermore, acetylcholinesterase (AChE) activity and neuronal apoptosis were significantly inhibited in rats treated with Aß(1-40) and EOCO compared to rats treated only with Aß(1-40). DISCUSSION AND CONCLUSION: EOCO suppressed both AD-related neuronal cell apoptosis and AD-related dysfunction of the memory system. Thus, the results of this study support EOCO as a candidate drug for the treatment of AD.
Asunto(s)
Péptidos beta-Amiloides/toxicidad , Chamaecyparis , Trastornos del Conocimiento/tratamiento farmacológico , Aceites Volátiles/administración & dosificación , Fragmentos de Péptidos/toxicidad , Extractos Vegetales/administración & dosificación , Administración por Inhalación , Péptidos beta-Amiloides/antagonistas & inhibidores , Animales , Trastornos del Conocimiento/inducido químicamente , Trastornos del Conocimiento/psicología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Aceites Volátiles/aislamiento & purificación , Fragmentos de Péptidos/antagonistas & inhibidores , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta , Distribución Aleatoria , Ratas , Ratas Sprague-DawleyRESUMEN
Ginseng saponin, the most important secondary metabolite in ginseng, has various pharmacological activities. Many studies have been directed towards converting major ginsenosides to the more active minor ginsenoside, Rg3. Due to the difficulty in preparing ginsenoside Rg3 enzymatically, the compound has been mainly produced by either acid treatment or heating. A microbial strain GS514 was isolated from soil around ginseng roots in a field and used for enzymatic preparation of the ginsenoside Rg3. Blast results of the 16S rRNA gene sequence of the strain GS514 established that the strain GS514 belonged to the genus Microbacterium. Its 16S rRNA gene sequence showed 98.7%, 98.4% and 96.1% identity with those of M. esteraromaticum, M. arabinogalactanolyticum and M. lacticum. Strain GS514 showed a strong ability to convert ginsenoside Rb1 or Rd into Rg3. Enzymatic production of Rg3 occurred by consecutive hydrolyses of the terminal and inner glucopyranosyl moieties at the C-20 carbon of ginsenoside Rb1 showing the biotransformation pathway: Rb1-->Rd-->Rg3.
Asunto(s)
Actinomycetales/metabolismo , Ginsenósidos/biosíntesis , Ginsenósidos/metabolismo , Actinomycetales/clasificación , Actinomycetales/genética , Actinomycetales/aislamiento & purificación , Biotransformación , Medios de Cultivo/química , Ginsenósidos/química , Isomerismo , Espectroscopía de Resonancia Magnética , Panax/química , Panax/metabolismo , Raíces de Plantas/química , Raíces de Plantas/metabolismo , ARN Ribosómico 16S/genética , Microbiología del Suelo , beta-Glucosidasa/metabolismoRESUMEN
Two novel strains belonging to the phylum Bacteroidetes [formerly the Cytophaga-Flexibacter-Bacteroides (CFB) group], designated Gsoil 040(T) and Gsoil 052(T), were isolated from the soil of a ginseng field in Pocheon province, South Korea. A polyphasic approach was used to characterize the taxonomic position of the novel strains. Both strains were Gram-negative, aerobic, non-motile, non-spore-forming and rod-shaped. Phylogenetic analysis based on 16S rRNA gene sequences indicated that the novel isolates belong to the genus Chitinophaga but are clearly separated from the recognized species of this genus; gene sequence similarities between the novel isolates and type strains of recognized species ranged from 91.2 to 96.5 %. One exception was found; strain Gsoil 052(T) and the type strain of Chitinophaga filiformis had a gene sequence similarity of 99.6 % but had a DNA-DNA relatedness value of 38 %. Phenotypic and chemotaxonomic data (major menaquinone, MK-7; major fatty acids, iso-C(15 : 0) and C(16 : 1)omega5c; major hydroxy fatty acid, iso-C(17 : 0) 3-OH and major polyamine, homospermidine) supported the affiliation of both strains Gsoil 040(T) and Gsoil 052(T) to the genus Chitinophaga. The results of physiological and biochemical tests enabled the genotypic and phenotypic differentiation of the novel strains from the other recognized species of the genus Chitinophaga. Therefore, it is suggested that the new isolates represent two novel species, for which the names Chitinophaga ginsengisoli [corrected] sp. nov. [type strain Gsoil 040(T) (=KCTC 12654(T)=DSM 18108(T))] and Chitinophaga ginsengisoli sp. nov. [type strain Gsoil 052(T) (=KCTC 12592(T)=DSM 18017(T))] are proposed.
Asunto(s)
Bacteroidetes/clasificación , Bacteroidetes/aislamiento & purificación , Microbiología del Suelo , Aerobiosis , Bacteroidetes/química , Bacteroidetes/genética , ADN Bacteriano/química , ADN Bacteriano/genética , ADN Ribosómico/química , ADN Ribosómico/genética , Ácidos Grasos/análisis , Genes de ARNr , Corea (Geográfico) , Locomoción , Microscopía Electrónica de Transmisión , Datos de Secuencia Molecular , Hibridación de Ácido Nucleico , Panax , Filogenia , Poliaminas/análisis , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Vitamina K 2/análisisRESUMEN
A Gram-positive, non-spore-forming, rod-shaped and non-motile bacterium, strain Gsoil 355(T), was isolated from soil of a ginseng field in South Korea. In phylogenetic analyses based on 16S rRNA gene sequences, strain Gsoil 355(T) showed the highest levels of sequence similarity with respect to Solirubrobacter pauli B33D1(T) (97.4 %), Conexibacter woesei DSM 14684(T) (94.2 %) and Patulibacter minatonensis KV-614(T) (91.8 %). The strain possesses menaquinone MK-7(H(4)) and contains C(16 : 0) and C(18 : 0) omega 9c as the predominant fatty acids. The DNA G+C content is 71.5 mol%. On the basis of genotypic and phenotypic characteristics, strain Gsoil 355(T) represents a novel species of the genus Solirubrobacter, for which the name Solirubrobacter soli sp. nov. is proposed. The type strain is Gsoil 355(T) (=KCTC 12628(T)=LMG 23485(T)).
Asunto(s)
Actinobacteria/clasificación , Actinobacteria/aislamiento & purificación , Microbiología del Suelo , Actinobacteria/química , Actinobacteria/fisiología , Composición de Base , ADN Bacteriano/química , ADN Bacteriano/genética , ADN Ribosómico/química , ADN Ribosómico/genética , Ácidos Grasos/análisis , Genes de ARNr , Corea (Geográfico) , Locomoción , Datos de Secuencia Molecular , Panax , Filogenia , ARN Bacteriano/genética , ARN Ribosómico 16S/genética , Análisis de Secuencia de ADN , Homología de Secuencia de Ácido Nucleico , Esporas Bacterianas , Vitamina K 2/análisisRESUMEN
A new strain, GS603, having beta-glucosidase activity was isolated from soil of a ginseng field, and its ability to convert major ginsenoside Rb(1) to minor ginsenoside or gypenoside was studied. Strain GS603 was identified as an Intrasporangium species by phylogenetic analysis and showed high ginsenoside-converting activity in LB and TSA broth but not in nutrient broth. The culture broth of the strain GS603 could convert ginsenoside Rb(1 )into two metabolites, which were analyzed by TLC and HPLC and shown to be the minor ginsenoside F(2) and gypenoside XVII by NMR.